|
 |
 |
||||||||
|
|||||||||
 |
 |
1. Folotyn Approved for Aggressive Type of Non-Hodgkin's Lymphoma - US News and World Report
For those who have relapsed or haven't responded to other therapies
2. Poverty Raises Mortality Risk With Non-Hodgkin Lymphoma - US News and World Report
MONDAY, Oct. 20 (HealthDay News) -- The risk of death for someone with non-Hodgkin lymphoma increases if one is poor but decreases if the person receives chemotherapy, a new study shows. The report, published in the Dec. 1 issue of Cancer, finds tha... Expand your search to include all of U.S. News
3. MabThera in aggressive non-Hodgkin's lymphoma
No summary available. http://virtualmedicalcentre.com/research.asp?artid=3833
4. MabThera in aggressive non-Hodgkin's lymphoma -- Medical Information
MabThera in aggressive non-Hodgkin's lymphoma Study of MabThera in aggressive non-Hodgkin's lymphoma in patients less than 60 years old halted two years ear... http://www.virtualmedicalcentre.com/research.asp?artid=3833
5. Rituximab for aggressive non-Hodgkins lymphoma. -- Ngc - National Guideline Clearinghouse
Rituximab for aggressive non-Hodgkin s lymphoma. Rituximab for aggressive non-Hodgkin's lymphoma. Rituximab (MabThera) for aggressive non Hodgkin's lymphoma... http://www.guideline.gov/summary/summary.aspx?view_id=1&doc_id=9093 |
advertisement |
- Subscriber Services |
- Site Map |
- About Us |
- Contact Us |
- Classroom Program |
- Marketplace |
- Store |
- Advertise With Us |
- Masthead
Use of this Web site constitutes acceptance of our Terms and Conditions of Use and Privacy Policy.